Arranta Bio Named Honoree in GrowFL Companies to Watch
Arranta Bio is pleased to be among the top 50 second-stage companies in Florida selected as honorees in the 2020 GrowFL Florida... Read More
Selecting a Microbiome CDMO Partner for the Long Term, Arranta Bio Shares
As more microbiome-based therapies progress through the clinic toward approval for market launch, concerns over the lack of outsourcing capacity for process... Read More
Arranta Bio Announces Completion of Its Microbiome Process Development Laboratory Expansion and Commitment to Additional Early Clinical GMP Capacity
Arranta Bio, the leading microbiome contract development and manufacturing organization (CDMO), announced the completion of its process development laboratory expansion project and... Read More
Oxidien Pharmaceuticals Announces Favorable Response from FDA on Proposed Development Plan
UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for secondary hyperoxaluria, announced... Read More
Arranta Bio Announces the Acquisition of Captozyme™, Creating a Center of Excellence for Microbiome Development and Clinical Supply
Arranta Bio, a contract development and manufacturing organization (CDMO), announced the acquisition of UF Innovate alumni startup Captozyme™, a leader in health... Read More
Captozyme Named to Gator100 List of Fastest Growing Companies
Captozyme Inc. was named among the top 50 fastest-growing UF alumni led businesses on the University of Florida’s annual 2019 Gator100. Captozyme... Read More
Resource Rich: UF Innovate | The Hub Offers Even More After Doubling in Size (Business in Greater Gainesville)
In January, The Hub opened the doors to an expansion that doubled the building to 100,000 square feet. The mixed-use business incubator... Read More
Captozyme Initiates Clinical Study of Nephure™ Oxalate-Reducing Enzyme (BusinessWire)
UF Innovate incubator graduate Captozyme, Inc. announced that it is initiating a prospective double-blind, randomized, placebo controlled, cross-over study, with Nephure™, an... Read More
